TNF-α and MTHFR Polymorphisms Associated with Cerebral Palsy in Chinese Infants

Ruiying Hou1, Xiuyu Ren2, Juan Wang2

  • 1Department of Pediatrics, Affiliated Hospital of Weifang Medical College, Weifang, Shandong, China.

Molecular Neurobiology
|December 10, 2015
PubMed

Insights

Genetic variations in TNF-α and MTHFR genes are linked to cerebral palsy (CP) development in Chinese infants. Specific gene polymorphisms and their interactions may increase CP risk, suggesting a role in pathogenesis.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Cerebral palsy (CP) pathogenesis is complex, with genetic and environmental factors implicated.
  • Tumor Necrosis Factor-alpha (TNF-α) and Methylenetetrahydrofolate Reductase (MTHFR) genes are crucial in inflammatory and metabolic pathways potentially relevant to CP.

Purpose of the Study:

  • To investigate the association between specific polymorphisms in TNF-α (rs361525, rs1799724) and MTHFR (rs1476413, rs9651118) genes and the risk of cerebral palsy in Chinese infants.
  • To explore the potential interaction effects of these polymorphisms on CP development.

Main Methods:

  • Genotyping of 105 CP patients and 114 healthy controls for selected TNF-α and MTHFR polymorphisms using TaqMan allelic discrimination assay.
  • Statistical analysis including Odds Ratios (OR) and 95% Confidence Intervals (CI) to assess the strength of associations.
  • Subgroup analysis based on gestational age and measurement of TNF-α protein concentrations.

Main Results:

  • Significant differences in allele distributions for TNF-α rs1799724 and both allele and genotype distributions for MTHFR rs9651118 between CP cases and controls.
  • Significant associations found between TNF-α rs361525 and MTHFR rs9651118 polymorphisms and CP, particularly in subgroups based on gestational age.
  • Elevated TNF-α protein levels in patients with the rs361525 GG genotype and a significantly increased risk of CP associated with the interaction of TNF-α rs1799724 and MTHFR rs9651118.

Conclusions:

  • Polymorphisms in TNF-α and MTHFR genes are potentially involved in the pathogenesis of cerebral palsy in Chinese infants.
  • The interaction between specific TNF-α and MTHFR polymorphisms may contribute to an increased risk of CP.
  • These findings highlight the role of genetic factors in CP etiology and suggest potential targets for future research.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
160.0K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
22.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
61